The recognition that SLO of inflammatory tumor-bearing hosts are poorly receptive to CCR7-dependent migration of MigDC and naïve TL may be relevant for proposed vaccination or adoptive TL therapies applied to such tumors. This evidence concerns the gene CCR7 and neoplasm.